Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.13 USD | +0.20% | -1.15% | -42.83% |
05-07 | Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value | CI |
05-02 | Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.83% | 730M | |
+4.34% | 106B | |
+6.81% | 23.47B | |
-14.17% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.37% | 16.78B | |
+7.52% | 14.41B | |
+38.54% | 12.86B | |
+322.46% | 8.78B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- SVB Financial Adjusts Aurinia Pharmaceuticals Price Target to $17 From $22, Maintains Outperform Rating